GleamWall
中文EN

ANDERA PARTNERS

PARIS I0 · SEC CIK 0001757283

2026Q22026Q1 9 earlier quarters 🔒
$206.48M2026Q2 reported value
8Positions
100.0%Top 10 weight · largest 33.6%
0 / 0New / sold out
Reported value over time$206.48M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

KMTS 33.6%
MLYS 20.8%
AVLN 14.8%
AGMB 9.7%
EVMN 9.0%
IVA 6.7%
ABVX 5.0%
NYXOAH S A 0.4%

2026Q2 top buys estimated at quarter-end value

IVA Added+$6.86M
KMTS Added+$851,909

2026Q2 top sells estimated at quarter-end value

EVMN Reduced-$6.72M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
KMTS KESTRA MED TECHNOLOGIES LTD $69.42M33.62%2,728,679 33,4871.2% $851,909 Added
MLYS MINERALYS THERAPEUTICS INC $42.95M20.80%1,591,917 00.0% — Unchanged
AVLN AVALYN PHARMACEUTICALS INC $30.61M14.82%929,824 929,824— — First reported
AGMB AGOMAB THERAPEUTICS NV $19.97M9.67%1,538,702 00.0% — Unchanged
EVMN EVOMMUNE INC $18.50M8.96%1,391,990 -505,372-26.6% -$6.72M Reduced
IVA INVENTIVA SA $13.73M6.65%3,633,181 1,815,00099.8% $6.86M Added
ABVX ABIVAX SA $10.41M5.04%78,125 00.0% — Unchanged
— NYXOAH S A $882,2760.43%522,057 00.0% — Unchanged